HomeAARD • NASDAQ
add
Aardvark Therapeutics Inc
Previous close
$12.73
Day range
$12.60 - $12.72
Year range
$11.55 - $19.58
Avg Volume
121.37K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.09M | 196.16% |
Net income | -4.18M | -98.29% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.09M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 82.36M | — |
Total assets | 83.74M | — |
Total liabilities | 3.16M | — |
Total equity | 80.58M | — |
Shares outstanding | 21.38M | — |
Price to book | -1.12 | — |
Return on assets | -14.89% | — |
Return on capital | -15.33% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -4.18M | -98.29% |
Cash from operations | -3.96M | -149.53% |
Cash from investing | -5.00K | — |
Cash from financing | 64.00K | — |
Net change in cash | -3.90M | -145.80% |
Free cash flow | -2.88M | — |
About
Founded
2017
Website
Employees
18
